-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

635. Myeloproliferative Syndromes: Basic Science: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Diseases, Bone Marrow Failure, Combinations, Therapies, Biological Processes, MPN, Polycythemia vera, thrombocythemia, Clinically relevant, Myeloid Malignancies, immune mechanism, inflammation, microenvironment, pathways
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Jelena D. Milosevic Feenstra1*, Fiorella Schischlik, PhD2*, Roland Jäger, PhD3*, Daniel Ivanov, MSc1,4*, Gregor Eisenwort, MD, PhD1,4*, Alexandra Keller, PhD4*, Michael Schuster, PhD2*, Emir Hadzijusufovic, DVM1,4,5*, Maria-Theresa Krauth, MD1,4*, Robert Spörk, MSc1,6*, Bettina Gisslinger, MSc4*, Elisabeth Koller, MD6*, Michael Fillitz, MD6*, Michael Pfeilstocker, MD1,6, Thamer Sliwa, MD6*, Felix Keil, MD1,6*, Christoph Bock, PhD2*, Heinz Gisslinger, MD4*, Robert Kralovics, PhD2,3 and Peter Valent, MD1,4

1Ludwig Boltzmann Institute for Hematology and Oncology, Vienna, Austria
2CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
3Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
4Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
5Department for Companion Animals and Horses, University Clinic for Small Animals, Internal Medicine Small Animals, University of Veterinary Medicine Vienna, Vienna, Austria
63rd Medical Department, Hematology & Oncology, Hanuschkrankenhaus, Vienna, Austria

Helene Duparc1*, Delphine Muller2*, Ileana Antony-Debre, PhD, PharmD2*, Caroline Marty, PhD2*, Najet Debili3*, Jean-Luc Villeval, PhD2*, Isabelle Plo3*, William Vainchenker4*, Laure Gilles, PhD5* and Hana Raslova3*

1INSERM, UMR1287, Gustave Roussy, Université Paris-Saclay, Equipe labellisée Ligue Nationale Contre le Cancer, Université Sorbonne Paris Cité, Université Paris Diderot., Villejuif, France
2INSERM, UMR1287, Gustave Roussy, Université Paris-Saclay, Equipe labellisée Ligue Nationale Contre le Cancer., Villejuif, France
3INSERM, UMR1287, Gustave Roussy, Université Paris-Saclay, Equipe labellisée Ligue Nationale Contre le Cancer, Equipe GRex, Villejuif, France
4Gustave Roussy, Villejuif, France
5INSERM, UMR1287, Gustave Roussy, Université Paris-Saclay, Equipe labellisée Ligue Nationale Contre le Cancer, Institut National de la Transfusion Sanguine, Villejuif, IL, France

Cesarina Giallongo, PhD1*, Mariarita Spampinato, Ph.D student2*, Enrico La Spina3*, Nunziatina Laura Parrinello, PhD4*, Lucia Longhitano, Ph.D student5*, Rosario Caltabiano, MD6*, Lucia Salvatorelli, MD6*, Alessandra Romano, MD, PhD7, Alessandro Barbato4*, Michelino Di Rosa, PhD8*, Giacomo Lazzarino, Ph.D.9*, Giovanni Li Volti, MD, PhD10*, Francesco Di Raimondo, MD11, Daniele Tibullo, PhD12* and Giuseppe A. Palumbo, MD, PhD13*

1Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, Catania, CT, Italy
2Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania,, University of Catania, Catania, Italy
3Division of Hematology, University of Catania, Catania, Italy
4Division of Hematology, Azienda Policlinico - OVE, University of Catania, Catania, Italy
5Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
6Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, Catania, Italy
7CHIRMED - Department of General Surgery and Medical-Surgical Specialties - Hematology Section, University of Catania, Tremestieri Etneo, Cantania, Italy
8Section of Human Anatomy, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
9UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy
10Department of Biomedical and Biotechnological Sciences, Univeristy of Catania, Catania, Italy
11Division of Hematology, A.O.U. "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy
12Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
13Department of Medical, Surgical and Advanced Technology "G.F. Ingrassia", University of Catania, Catania, Italy

Paola Verachi1*, Fabrizio Martelli, PhD2*, Maria Zingariello, PhD3*, Shalini Chaturvedi4*, Celine Wilke, MD5*, Valerie Campello-Iddison, MD6* and Anna Rita Migliaccio, PhD1,7

1Biomedical and Neuromotorial Sciences, Alma Mater Studiorum University, Bologna, Italy
2Istituto Superiore di Sanità, Rome, Italy
3Unit of Microscopic and Ultrastructural Anatomy, Dept of Medicine, University Campus Bio-Medico, Rome, Italy
4Novartis Pharmaceuticals Corporation, East Hanover, NJ
5Novartis Pharma AG, Basel, Switzerland
6Novartis, East Hanover, NJ
7Myeloproliferative Neoplasm-Research Consortium, New York, NY

Tadaaki Inano, MD, PhD1*, Marito Araki, PhD2*, Soji Morishita, PhD2*, Misa Imai, PhD1,3*, Yoshihiko Kihara1,3*, Maho Okuda, PhD1,4*, Masafumi Ito, MD, PhD5*, Satoshi Osaga6*, Yinjie Yang, PhD1*, Yoko Edahiro, MD, PhD1*, Tomonori Ochiai, MD, PhD1*, Kyohei Misawa, MD, PhD1*, Yasutaka Fukuda, MD, PhD1*, Akimichi Ohsaka, MD, PhD2* and Norio Komatsu, MD, PhD1

1Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan
2Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan
3Leading Center for the Development and Research of Cancer Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
4Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
5Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
6Clinical Research Management Center, Nagoya City University Hospital, Nagoya, Japan

Antonella Zagaria1*, Francesco Tarantini, MD2*, Luisa Anelli3*, Paola Orsini3*, Angela Minervini1*, Nicoletta Coccaro3*, Elisa Parciante3*, Crescenzio Francesco Minervini3*, Cosimo Cumbo3*, Giuseppina Tota3*, Luciana Impera3*, Maria Rosa Conserva4*, Immacolata Redavid4*, Alessandra Ricco, MD3*, Immacolata Attolico, MD4*, Giorgina Specchia, MD5, Pellegrino Musto, MD6 and Francesco Albano4*

1Hematology and Stem cell Transplantation Unit - Dept. of Emergency and Organ Transplantation - University of Bari, Bari, Italy
2Hematology and Stem cell Transplantation Unit - Department of Emergency and Organ Transplantation (D.E.T.O.) - University of Bari, Bari, Italy
3Hematology and Stem cell Transplantation Unit - Dept. of Emergency and Organ Transplantation - University of Bari, Bari, Italy
4Hematology and Stem cell Transplantation Unit - Department of Emergency and Organ Transplantation (D.E.T.O.) - University of Bari, Bari, Italy
5University Policlinico, Bari, Ba, Italy
6Hematology and Stem cell Transplantation Unit - Department of Emergency and Organ Transplantation (D.E.T.O.) - University of Bari, Bari, Italy

*signifies non-member of ASH